Upstream Bio, Inc. (UPB) operating KPIs

UPBNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 9/30

$3.41+0.14 (+4.28%)

Close on Oct 30, 2026Market cap $186.77MP/E –Yield –

KPIs

Operating metrics that drive Upstream Bio's business

Rentable area (sq ft)	Q2 26	Q1 26	Q3 25	Q2 25	Q1 25	Q3 24	YoY
Rentable area	16,801	16,801	16,801	16,801	16,801	16,801	0.0%

Counts and sizes Upstream Bio tags in the notes of its 10-K and 10-Q filings (XBRL), as of the end of each quarter. Breakdowns follow the company's own labels; at most 15 are shown per metric. A fuller KPI sheet built from earnings releases and presentations is on the way. See how companies compare on these metrics.